Vasculitis Trial, Recruiting (NCT06779799)

Vasculitis Trial, Recruiting NCT06779799 Sponsor: University Hospital, Brest Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT06779799 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with a systemic autoimmune disease, such as rheumatoid arthritis, lupus, systemic sclerosis, primary Sjögren's disease, sarcoidosis, vasculitis, myositis, Still's disease, or Sharp syndrome
You are experiencing voice problems or hoarseness (called dysphonia)
A scan or examination has found a change or abnormality on your vocal cords or in your voice box (larynx)

Who may not be able to join:

You are under 18 years old
Your voice problems are caused by a nerve or neurological condition, or by cancer affecting the vocal cords
You have previously had radiation treatment to your neck area
You have previously had a breathing tube placed down your throat (such as during surgery or intensive care)
You have been diagnosed with cancer of the voice box (laryngeal cancer)
You do not wish to take part in the trial
You are unable to give your own consent to participate
You are currently under a legal protection order (such as guardianship or court-appointed protection) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0298347264

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06779799

Sponsor: University Hospital, Brest

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: 0298347264

More information: https://clinicaltrials.gov/study/NCT06779799

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with a systemic autoimmune disease, such as rheumatoid arthritis, lupus, systemic sclerosis, primary Sjögren's disease, sarcoidosis, vasculitis, myositis, Still's disease, or Sharp syndrome
You are experiencing voice problems or hoarseness (called dysphonia)
A scan or examination has found a change or abnormality on your vocal cords or in your voice box (larynx)

Who may not be able to join:

You are under 18 years old
Your voice problems are caused by a nerve or neurological condition, or by cancer affecting the vocal cords
You have previously had radiation treatment to your neck area
You have previously had a breathing tube placed down your throat (such as during surgery or intensive care)
You have been diagnosed with cancer of the voice box (laryngeal cancer)
You do not wish to take part in the trial
You are unable to give your own consent to participate
You are currently under a legal protection order (such as guardianship or court-appointed protection) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Brest

Registry

ClinicalTrials.gov

Start date

1 December 2024

Est. completion

31 May 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Nature of the cord vocal lesion responsible for dysphonia according to the physician (otorhinolaryngologist, rheumatologist or internist) from medical record

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov